COMPASS Pathways announces further positive results from groundbreaking phase IIb trial of investigational COMP360 psilocybin therapy for treatment-resistant depression
COMPASS Pathways to participate in upcoming Evercore, H.C. Wainwright & Berenberg investor conferences
Psychedelics Investing Stocks2Watch's Virtual Investor Luncheon Agenda Updated for Tuesday November 30
Psychedelics Investing NeonMind Announces Successful Completion of Pre-IND Consultation with FDA on Clinical Path for Obesity Drug Candidate NEO-001
Psychedelics Investing Stocks2Watch to Host Investor Luncheon with Special Guest, Bruce Campbell from StoneCastle Investment Management, Tuesday November 30th
Psychedelics Investing Hollister Biosciences Announces Third Quarter Fiscal 2021 Financial Results Including Revenue of USD $14.5M and Adjusted Ebitda of USD $1.2M
Psychedelics Investing iX Biopharma Signs Exclusive License Agreement For Wafermine And Other Sublingual Ketamine Wafer Products
Psychedelics Investing Seelos Therapeutics Announces Acquisition of an Exclusive License of iX Biopharma's Proprietary Wafer-Based Delivery Platform for Sublingual Ketamine
Psychedelics Investing Seelos Therapeutics Raises $20 Million in Private Placement of Senior Secured Convertible Note
Psychedelics Investing Hollister Biosciences Inc. Announces Results of Its 2021 Annual General and Special Shareholder Meeting
Psychedelics Investing Hollister Biosciences Inc. to Report Q3 2021 Financial Results on November 29, 2021
Psychedelics Investing NeonMind to Participate in Panel Discussion at Lift & Co. Expo's Psychedelics Business Summit on November 19, 2021
Psychedelics Investing BetterLife Obtains TD-0148A Behavioural Pharmacology Data Confirming its Projected Non-hallucinogenic Property
Psychedelics Investing Awakn Life Sciences Signs MOU with NHS and University of Exeter with a View of Increasing Access to Psychedelic-Assisted Psychotherapy in the UK
Psychedelics Investing Levitee Labs Appoints Noha ElSayed as Executive Director for Levitee Clinics and Levitee Pharmacies in the Alberta Region
Psychedelics Investing Levitee Labs Appoints Noha ElSayed as Executive Director for Levitee Clinics and Levitee Pharmacies in the Alberta Region
